MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals board to consider un-audited financial results

01 Jul 2016 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on July 28, 2016, to consider and approve Un-Audited Financial Results for the first quarter ended June 30, 2016 (Q1).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..